We are live on ! Find out more
CNMD icon

CONMED
CNMD

252 hedge funds and large institutions have $4.32B invested in CONMED in 2021 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 94 increasing their positions, 78 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

85% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 20

21% more repeat investments, than reductions

Existing positions increased: 94 | Existing positions reduced: 78

6% more capital invested

Capital invested by funds: $4.05B → $4.32B (+$263M)

6% more funds holding

Funds holding: 238 → 252 (+14)

0.7% more ownership

Funds ownership: 107.26% → 107.97% (+0.7%)

93% less call options, than puts

Call options by funds: $1.95M | Put options by funds: $26.6M

Holders
252
Holders Change
+14
Holders Change %
+5.88%
% of All Funds
4.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
37
Increased
94
Reduced
78
Closed
20
Calls
$1.95M
Puts
$26.6M
Net Calls
-$24.6M
Net Calls Change
-$6.48M

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$59.8M
2
Aberdeen Group
Aberdeen Group
United Kingdom
+$37.2M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$28.5M
4
Victory Capital Management
Victory Capital Management
Texas
+$28M
5
Ameriprise
Ameriprise
Minnesota
+$19.4M

Top Sellers

Rank Fund Capital Flow
1
CVA
Ceredex Value Advisors
Florida
-$42.5M
2
HM
HealthCor Management
New York
-$36.2M
3
CIP
Champlain Investment Partners
Vermont
-$31.3M
4
Millennium Management
Millennium Management
New York
-$25.3M
5
BlackRock
BlackRock
New York
-$16.6M

CNMD Hedge Fund Activity: Q2 2021 in Review

252 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q2 2021, worth a combined $4.32B — up 6.5% from $4.05B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new CNMD positions and 20 closed out — a net gain of 17 holders — while 94 added to existing stakes and 78 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $59.8M. The largest seller was Ceredex Value Advisors, exiting entirely with an estimated $42.5M sold.

  • 252 institutional investors held CONMED (CNMD) as of Q2 2021, up from 238 in Q1 2021.
  • Funds reported $4.32B of CONMED stock for Q2 2021, up 6.5% quarter-over-quarter.
  • 37 funds opened new CONMED positions in Q2 2021 and 20 closed out, a net change of +17 holders.
  • The largest CONMED buyer in Q2 2021 was JP Morgan Chase, an estimated $59.8M added.
  • The largest CONMED seller in Q2 2021 was Ceredex Value Advisors, an estimated $42.5M sold.

Based on aggregated 13F filings for Q2 2021.